PDCD1 and hepatocellular carcinoma: To investigate the role of circRNAs in HCC patients treated with anti-PD1, 6 patients with advanced HCC treated with nivolumab (human anti-PD1 antibody, Bristol Myers Squibb) were analyzed based on retrospective data.